Cargando…

SARS-CoV-2 spike L452R variant evades cellular immunity and increases infectivity

Many SARS-CoV-2 variants with naturally acquired mutations have emerged. These mutations can affect viral properties such as infectivity and immune resistance. Although the sensitivity of naturally occurring SARS-CoV-2 variants to humoral immunity has been investigated, sensitivity to human leukocyt...

Descripción completa

Detalles Bibliográficos
Autores principales: Motozono, Chihiro, Toyoda, Mako, Zahradnik, Jiri, Saito, Akatsuki, Nasser, Hesham, Tan, Toong Seng, Ngare, Isaac, Kimura, Izumi, Uriu, Keiya, Kosugi, Yusuke, Yue, Yuan, Shimizu, Ryo, Ito, Jumpei, Torii, Shiho, Yonekawa, Akiko, Shimono, Nobuyuki, Nagasaki, Yoji, Minami, Rumi, Toya, Takashi, Sekiya, Noritaka, Fukuhara, Takasuke, Matsuura, Yoshiharu, Schreiber, Gideon, Ikeda, Terumasa, Nakagawa, So, Ueno, Takamasa, Sato, Kei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Authors. Published by Elsevier Inc. 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8205251/
https://www.ncbi.nlm.nih.gov/pubmed/34171266
http://dx.doi.org/10.1016/j.chom.2021.06.006
_version_ 1783708470694903808
author Motozono, Chihiro
Toyoda, Mako
Zahradnik, Jiri
Saito, Akatsuki
Nasser, Hesham
Tan, Toong Seng
Ngare, Isaac
Kimura, Izumi
Uriu, Keiya
Kosugi, Yusuke
Yue, Yuan
Shimizu, Ryo
Ito, Jumpei
Torii, Shiho
Yonekawa, Akiko
Shimono, Nobuyuki
Nagasaki, Yoji
Minami, Rumi
Toya, Takashi
Sekiya, Noritaka
Fukuhara, Takasuke
Matsuura, Yoshiharu
Schreiber, Gideon
Ikeda, Terumasa
Nakagawa, So
Ueno, Takamasa
Sato, Kei
author_facet Motozono, Chihiro
Toyoda, Mako
Zahradnik, Jiri
Saito, Akatsuki
Nasser, Hesham
Tan, Toong Seng
Ngare, Isaac
Kimura, Izumi
Uriu, Keiya
Kosugi, Yusuke
Yue, Yuan
Shimizu, Ryo
Ito, Jumpei
Torii, Shiho
Yonekawa, Akiko
Shimono, Nobuyuki
Nagasaki, Yoji
Minami, Rumi
Toya, Takashi
Sekiya, Noritaka
Fukuhara, Takasuke
Matsuura, Yoshiharu
Schreiber, Gideon
Ikeda, Terumasa
Nakagawa, So
Ueno, Takamasa
Sato, Kei
author_sort Motozono, Chihiro
collection PubMed
description Many SARS-CoV-2 variants with naturally acquired mutations have emerged. These mutations can affect viral properties such as infectivity and immune resistance. Although the sensitivity of naturally occurring SARS-CoV-2 variants to humoral immunity has been investigated, sensitivity to human leukocyte antigen (HLA)-restricted cellular immunity remains largely unexplored. Here, we demonstrate that two recently emerging mutations in the receptor-binding domain of the SARS-CoV-2 spike protein, L452R (in B.1.427/429 and B.1.617) and Y453F (in B.1.1.298), confer escape from HLA-A24-restricted cellular immunity. These mutations reinforce affinity toward the host entry receptor ACE2. Notably, the L452R mutation increases spike stability, viral infectivity, viral fusogenicity, and thereby promotes viral replication. These data suggest that HLA-restricted cellular immunity potentially affects the evolution of viral phenotypes and that a further threat of the SARS-CoV-2 pandemic is escape from cellular immunity.
format Online
Article
Text
id pubmed-8205251
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher The Authors. Published by Elsevier Inc.
record_format MEDLINE/PubMed
spelling pubmed-82052512021-06-16 SARS-CoV-2 spike L452R variant evades cellular immunity and increases infectivity Motozono, Chihiro Toyoda, Mako Zahradnik, Jiri Saito, Akatsuki Nasser, Hesham Tan, Toong Seng Ngare, Isaac Kimura, Izumi Uriu, Keiya Kosugi, Yusuke Yue, Yuan Shimizu, Ryo Ito, Jumpei Torii, Shiho Yonekawa, Akiko Shimono, Nobuyuki Nagasaki, Yoji Minami, Rumi Toya, Takashi Sekiya, Noritaka Fukuhara, Takasuke Matsuura, Yoshiharu Schreiber, Gideon Ikeda, Terumasa Nakagawa, So Ueno, Takamasa Sato, Kei Cell Host Microbe Short Article Many SARS-CoV-2 variants with naturally acquired mutations have emerged. These mutations can affect viral properties such as infectivity and immune resistance. Although the sensitivity of naturally occurring SARS-CoV-2 variants to humoral immunity has been investigated, sensitivity to human leukocyte antigen (HLA)-restricted cellular immunity remains largely unexplored. Here, we demonstrate that two recently emerging mutations in the receptor-binding domain of the SARS-CoV-2 spike protein, L452R (in B.1.427/429 and B.1.617) and Y453F (in B.1.1.298), confer escape from HLA-A24-restricted cellular immunity. These mutations reinforce affinity toward the host entry receptor ACE2. Notably, the L452R mutation increases spike stability, viral infectivity, viral fusogenicity, and thereby promotes viral replication. These data suggest that HLA-restricted cellular immunity potentially affects the evolution of viral phenotypes and that a further threat of the SARS-CoV-2 pandemic is escape from cellular immunity. The Authors. Published by Elsevier Inc. 2021-07-14 2021-06-15 /pmc/articles/PMC8205251/ /pubmed/34171266 http://dx.doi.org/10.1016/j.chom.2021.06.006 Text en © 2021 The Authors Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.
spellingShingle Short Article
Motozono, Chihiro
Toyoda, Mako
Zahradnik, Jiri
Saito, Akatsuki
Nasser, Hesham
Tan, Toong Seng
Ngare, Isaac
Kimura, Izumi
Uriu, Keiya
Kosugi, Yusuke
Yue, Yuan
Shimizu, Ryo
Ito, Jumpei
Torii, Shiho
Yonekawa, Akiko
Shimono, Nobuyuki
Nagasaki, Yoji
Minami, Rumi
Toya, Takashi
Sekiya, Noritaka
Fukuhara, Takasuke
Matsuura, Yoshiharu
Schreiber, Gideon
Ikeda, Terumasa
Nakagawa, So
Ueno, Takamasa
Sato, Kei
SARS-CoV-2 spike L452R variant evades cellular immunity and increases infectivity
title SARS-CoV-2 spike L452R variant evades cellular immunity and increases infectivity
title_full SARS-CoV-2 spike L452R variant evades cellular immunity and increases infectivity
title_fullStr SARS-CoV-2 spike L452R variant evades cellular immunity and increases infectivity
title_full_unstemmed SARS-CoV-2 spike L452R variant evades cellular immunity and increases infectivity
title_short SARS-CoV-2 spike L452R variant evades cellular immunity and increases infectivity
title_sort sars-cov-2 spike l452r variant evades cellular immunity and increases infectivity
topic Short Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8205251/
https://www.ncbi.nlm.nih.gov/pubmed/34171266
http://dx.doi.org/10.1016/j.chom.2021.06.006
work_keys_str_mv AT motozonochihiro sarscov2spikel452rvariantevadescellularimmunityandincreasesinfectivity
AT toyodamako sarscov2spikel452rvariantevadescellularimmunityandincreasesinfectivity
AT zahradnikjiri sarscov2spikel452rvariantevadescellularimmunityandincreasesinfectivity
AT saitoakatsuki sarscov2spikel452rvariantevadescellularimmunityandincreasesinfectivity
AT nasserhesham sarscov2spikel452rvariantevadescellularimmunityandincreasesinfectivity
AT tantoongseng sarscov2spikel452rvariantevadescellularimmunityandincreasesinfectivity
AT ngareisaac sarscov2spikel452rvariantevadescellularimmunityandincreasesinfectivity
AT kimuraizumi sarscov2spikel452rvariantevadescellularimmunityandincreasesinfectivity
AT uriukeiya sarscov2spikel452rvariantevadescellularimmunityandincreasesinfectivity
AT kosugiyusuke sarscov2spikel452rvariantevadescellularimmunityandincreasesinfectivity
AT yueyuan sarscov2spikel452rvariantevadescellularimmunityandincreasesinfectivity
AT shimizuryo sarscov2spikel452rvariantevadescellularimmunityandincreasesinfectivity
AT itojumpei sarscov2spikel452rvariantevadescellularimmunityandincreasesinfectivity
AT toriishiho sarscov2spikel452rvariantevadescellularimmunityandincreasesinfectivity
AT yonekawaakiko sarscov2spikel452rvariantevadescellularimmunityandincreasesinfectivity
AT shimononobuyuki sarscov2spikel452rvariantevadescellularimmunityandincreasesinfectivity
AT nagasakiyoji sarscov2spikel452rvariantevadescellularimmunityandincreasesinfectivity
AT minamirumi sarscov2spikel452rvariantevadescellularimmunityandincreasesinfectivity
AT toyatakashi sarscov2spikel452rvariantevadescellularimmunityandincreasesinfectivity
AT sekiyanoritaka sarscov2spikel452rvariantevadescellularimmunityandincreasesinfectivity
AT fukuharatakasuke sarscov2spikel452rvariantevadescellularimmunityandincreasesinfectivity
AT matsuurayoshiharu sarscov2spikel452rvariantevadescellularimmunityandincreasesinfectivity
AT schreibergideon sarscov2spikel452rvariantevadescellularimmunityandincreasesinfectivity
AT sarscov2spikel452rvariantevadescellularimmunityandincreasesinfectivity
AT ikedaterumasa sarscov2spikel452rvariantevadescellularimmunityandincreasesinfectivity
AT nakagawaso sarscov2spikel452rvariantevadescellularimmunityandincreasesinfectivity
AT uenotakamasa sarscov2spikel452rvariantevadescellularimmunityandincreasesinfectivity
AT satokei sarscov2spikel452rvariantevadescellularimmunityandincreasesinfectivity